vimarsana.com

Latest Breaking News On - Granahan investment management inc - Page 11 : vimarsana.com

Evolent Health (NYSE:EVH) Price Target Raised to $40 00

Evolent Health (NYSE:EVH – Get Rating) had its target price upped by BTIG Research from $35.00 to $40.00 in a research report report published on Friday morning, The Fly reports. They currently have a buy rating on the technology company’s stock. EVH has been the topic of a number of other reports. Piper Sandler dropped […]

Green Brick Partners, Inc (NASDAQ:GRBK) Shares Sold by Russell Investments Group Ltd

Russell Investments Group Ltd. lessened its holdings in shares of Green Brick Partners, Inc. (NASDAQ:GRBK – Get Rating) by 3.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 424,473 shares of the financial services provider’s stock after selling 15,639 shares during the quarter. Russell Investments Group Ltd. […]

Railway Pension Investments Ltd Invests $813,000 in ThredUp Inc (NASDAQ:TDUP)

Railway Pension Investments Ltd bought a new position in ThredUp Inc. (NASDAQ:TDUP – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 63,700 shares of the company’s stock, valued at approximately $813,000. Railway Pension Investments Ltd owned […]

Sprinklr (NYSE:CXM) PT Lowered to $18 00 at Stifel Nicolaus

Sprinklr (NYSE:CXM – Get Rating) had its price target decreased by Stifel Nicolaus from $26.00 to $18.00 in a research note released on Monday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Several other equities analysts also recently weighed in on the stock. Barclays decreased their price target on shares of […]

Zacks: Brokerages Expect Cytosorbents Co (NASDAQ:CTSO) Will Post Quarterly Sales of $9 84 Million

Wall Street brokerages expect Cytosorbents Co. (NASDAQ:CTSO – Get Rating) to report sales of $9.84 million for the current quarter, according to Zacks. Five analysts have made estimates for Cytosorbents’ earnings. The highest sales estimate is $10.30 million and the lowest is $9.16 million. Cytosorbents posted sales of $10.60 million during the same quarter last […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.